Purchase Order 75N93019P01215

This is a $3,300 firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services. The contract is to extend the storage period of a cryopreserved strain of G6PCFX/FX sperm, which are likely specialized genetically engineered mouse models used in biomedical research. The awardee is the Jackson Laboratory, a nonprofit research institution that frequently partners with...

This is a $35,160 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company, for the generation of a THRB-Cre-ERT2 knock-in mouse model. The work involves designing and constructing a targeting vector, selecting recombinant embryonic stem cell clones, and generating founder mice carrying the...

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $9,000 purchase order to Cyagen Biosciences Inc. to generate DNCPE mice for a cancer study. The firm fixed price contract will be performed in Bethesda, Maryland over a four month period concluding in September 2017. No major subcontractors or set aside designations were indicated. The National Institute of Child Health and Human Development supports...

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a firm fixed price purchase order valued at twenty-one thousand two hundred ninety-two dollars and fifty cents ($21,292.50) to Cyagen Biosciences Inc. of Santa Clara, California. The contract is for the delivery of a guaranteed germline package of HUMAN GPR101 E308D mutant knockin mice to the agency. Performance will take place in Santa Clara, California...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $14,572 firm fixed price purchase order to Ozgene PTY LTD of Australia. Under the contract, Ozgene will breed 40 mice and remove the CRE gene to support the agency's biomedical research efforts. The contract has a period of performance from September 24, 2014 through December 31, 2014 and will be carried out in Australia. No major subcontractors or set...

This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of "Live Animals, Not Raised for Food" and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $8,576.00, is for the breeding of ONO HCF-1 conditional knockout mice for removal of FLPAMBIS. No set-aside...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,450.00 firm fixed price purchase order to Applied Stemcell, Inc. to investigate cellular dysfunction associated with hereditary mutation within the prion gene. The contractor must generate two homozygous clones with the E200K prion gene mutation removed and two clones without the mutation removed, validating pluripotency and gene sequence. This requirement...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Genoway, a global biotechnology company, to provide services related to the revitalization, shipment, and establishment of replacement embryos for the YAN1 and YAN2 mouse lines. The potential value of the contract is $22,800.00, and it has a completion date of August 9, 2022. Genoway has previously provided similar services to the DHHS FDA, including the development...

This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...